Skip to main content

Advertisement

Figure 5 | BMC Pharmacology and Toxicology

Figure 5

From: Safety and pharmacological characterization of the molecular tweezer CLR01 – a broad-spectrum inhibitor of amyloid proteins’ toxicity

Figure 5

Correction for radioactivity from residual blood in the brain. Comparison of brain perfusion to remove residual blood with subtraction of calculated levels of blood radioactivity at 10 μl of blood per g of brain tissue. Data are given as mean ± SEM. The results were not significantly different and the subtraction method was used in the following experiments.

Back to article page